AbbVie Inc. (ABBV) Social Stream



AbbVie Inc. (ABBV): $138.18

0.54 (+0.39%)

POWR Rating

Component Grades

Momentum

B

Stability

B

Sentiment

Quality

A

Add ABBV to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#3 of 169

in industry

ABBVIE INC (ABBV) Price Targets From Analysts

Use the tables below to see what analysts covering ABBVIE INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 13 $140 $118 $128 $133.44 -4.08%
2021-11-23 12 $172 $118 $133.083 $133.44 -0.27%
2022-01-03 13 $172 $118 $135.538 $133.44 1.57%
2022-01-05 13 $172 $118 $140.923 $133.44 5.61%
2022-01-14 13 $172 $118 $143.416 $133.44 7.48%
2022-01-19 13 $172 $118 $147.166 $133.44 10.29%
2022-02-01 13 $172 $133 $149.916 $133.44 12.35%
2022-02-03 13 $180 $133 $151.416 $133.44 13.47%
2022-02-14 13 $180 $133 $153.5 $133.44 15.03%
2022-02-17 14 $180 $133 $154.083 $133.44 15.47%
2022-03-08 14 $180 $133 $153.538 $133.44 15.06%
2022-03-16 14 $180 $133 $154.076 $133.44 15.46%
2022-04-06 13 $192 $133 $159.833 $133.44 19.78%
2022-04-13 12 $192 $147 $163.25 $133.44 22.34%
2022-04-18 13 $192 $147 $165.75 $133.44 24.21%
2022-04-22 13 $192 $147 $166.083 $133.44 24.46%
2022-04-29 13 $192 $147 $167.833 $133.44 25.77%
2022-05-02 13 $200 $147 $170.75 $133.44 27.96%
2022-05-11 13 $200 $147 $168.846 $133.44 26.53%
2022-05-20 14 $200 $140 $166.785 $133.44 24.99%
2022-06-09 15 $200 $140 $165 $133.44 23.65%
2022-07-22 15 $200 $140 $165.2 $133.44 23.8%
2022-07-29 14 $200 $140 $165.2 $133.44 23.8%
2022-08-01 16 $200 $140 $165 $133.44 23.65%
2022-08-24 15 $200 $140 $163.562 $133.44 22.57%
2022-09-21 16 $200 $140 $163.562 $133.44 22.57%
2022-10-03 16 $200 $135 $163.25 $133.44 22.34%
2022-10-12 16 $200 $135 $163.062 $133.44 22.2%
2022-10-28 16 $200 $135 $163.312 $133.44 22.39%
2022-10-31 16 $200 $135 $162.25 $133.44 21.59%
2022-11-01 16 $200 $135 $161.937 $133.44 21.36%
2022-12-04 16 $200 $135 $161.266 $133.44 20.85%
2022-12-05 16 $200 $135 $161.4 $133.44 20.95%
2022-12-06 16 $200 $135 $161.666 $133.44 21.15%
2022-12-13 15 $200 $135 $161.866 $133.44 21.3%
2023-01-04 15 $200 $135 $162.533 $133.44 21.8%
2023-01-11 15 $200 $135 $164.571 $133.44 23.33%
2023-01-27 15 $200 $135 $164.714 $133.44 23.44%
2023-02-08 15 $200 $135 $164.357 $133.44 23.17%
2023-02-09 15 $200 $135 $164.571 $133.44 23.33%
2023-02-13 15 $200 $140 $166 $133.44 24.4%
2023-03-31 16 $200 $140 $165.733 $133.44 24.2%
2023-04-10 16 $200 $140 $165.933 $133.44 24.35%
2023-04-26 15 $200 $146 $168.142 $133.44 26.01%
2023-04-28 16 $195 $146 $167.714 $133.44 25.68%
2023-05-05 16 $195 $146 $167.785 $133.44 25.74%
2023-05-22 16 $195 $146 $169.153 $133.44 26.76%

The Trend in the Analyst Price Target


Over the past 43 weeks, ABBV's average price target has gone up $3.95.

Over the past 50 weeks, ABBV's average upside potential has been 9.76%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-01 15 200 140 163.625 140.22 16.69%
2022-09-10 16 200 140 163.562 141.42 15.66%
2022-09-17 16 200 140 163.562 144.06 13.54%
2022-10-13 16 200 135 163.312 142.92 14.27%
2022-10-31 16 200 135 162.250 146.40 10.83%

ABBV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.03 7 1 8 0 0 16

The Trend in the Broker Recommendations


Over the past 26 weeks, ABBV's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, ABBVIE INC's average analyst price target is greater than 5019.05% of them.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ABBVIE INC's number of analysts covering the stock is greater than 5171.38% of them.
  • In terms of how ABBVIE INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1032.08% of that group.
  • In the context of Pharmaceutical Products stocks, ABBVIE INC's variance in analysts' estimates is lower than -1101% of them.

In the Pharmaceutical Products industry, MRK, JNJ, and PFE are the three stocks most similar to ABBVIE INC regarding the price target and analyst recommendation information presented here.

Is ABBV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6577 seconds.